Safety and Efficacy of Kanglaite Gelcaps in Prostate Cancer
Status:
Terminated
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
This research is being done to evaluate the safety and efficacy of the investigational
Kanglaite gelcap (KLTc) on PSA in men with prostate cancer when given for twelve months.